The complexity of Rett syndrome models: Primary fibroblasts as a disease-in-a-dish reliable approach

Q3 Pharmacology, Toxicology and Pharmaceutics Drug Discovery Today: Disease Models Pub Date : 2020-06-01 DOI:10.1016/j.ddmod.2019.11.001
Valeria Cordone , Alessandra Pecorelli , Fernanda Amicarelli , Joussef Hayek , Giuseppe Valacchi
{"title":"The complexity of Rett syndrome models: Primary fibroblasts as a disease-in-a-dish reliable approach","authors":"Valeria Cordone ,&nbsp;Alessandra Pecorelli ,&nbsp;Fernanda Amicarelli ,&nbsp;Joussef Hayek ,&nbsp;Giuseppe Valacchi","doi":"10.1016/j.ddmod.2019.11.001","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Rett syndrome (RTT) is a progressive neurodevelopmental disease, which affects almost exclusively the female gender (prevalence of about 1:10,000). RTT symptoms are usually characterized by loss of purposeful hand skills, </span>mental retardation<span> and motor impairment, resulting in a plethora of other systemic co-morbidities. Mutations in the methyl-CpG binding protein 2 gene (</span></span><em>MECP2</em><span><span>) are the main genetic cause of the disorder, however molecular mechanisms leading from MeCP2 defects to this complicated pathology still need to be clarified. To investigate this and other aspects of RTT, several experimental models have been generated that include </span>animal models, and </span><em>in vitro</em> approaches. In this article we briefly summarized the main models used for RTT investigations, and special focus is given to the use of primary fibroblasts isolated from RTT patients, since they represent a reliable disease-in-a-dish model, which can help researcher to elucidate cellular and molecular mechanisms of this disease.</p></div>","PeriodicalId":39774,"journal":{"name":"Drug Discovery Today: Disease Models","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ddmod.2019.11.001","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today: Disease Models","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1740675719300404","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 8

Abstract

Rett syndrome (RTT) is a progressive neurodevelopmental disease, which affects almost exclusively the female gender (prevalence of about 1:10,000). RTT symptoms are usually characterized by loss of purposeful hand skills, mental retardation and motor impairment, resulting in a plethora of other systemic co-morbidities. Mutations in the methyl-CpG binding protein 2 gene (MECP2) are the main genetic cause of the disorder, however molecular mechanisms leading from MeCP2 defects to this complicated pathology still need to be clarified. To investigate this and other aspects of RTT, several experimental models have been generated that include animal models, and in vitro approaches. In this article we briefly summarized the main models used for RTT investigations, and special focus is given to the use of primary fibroblasts isolated from RTT patients, since they represent a reliable disease-in-a-dish model, which can help researcher to elucidate cellular and molecular mechanisms of this disease.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Rett综合征模型的复杂性:原代成纤维细胞作为盘中疾病的可靠方法
Rett综合征(RTT)是一种进行性神经发育疾病,几乎只影响女性(患病率约为1:10 000)。RTT的症状通常以手部目的性技能丧失、智力迟钝和运动障碍为特征,导致大量其他系统性合并症。甲基cpg结合蛋白2基因(MECP2)突变是该疾病的主要遗传原因,但MECP2缺陷导致这种复杂病理的分子机制仍有待阐明。为了研究RTT的这方面和其他方面,已经建立了几个实验模型,包括动物模型和体外方法。在本文中,我们简要总结了用于RTT研究的主要模型,并特别关注从RTT患者身上分离的原代成纤维细胞的使用,因为它们代表了一种可靠的疾病培养皿模型,可以帮助研究人员阐明该疾病的细胞和分子机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drug Discovery Today: Disease Models
Drug Discovery Today: Disease Models Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
自引率
0.00%
发文量
0
期刊介绍: Drug Discovery Today: Disease Models discusses the non-human experimental models through which inference is drawn regarding the molecular aetiology and pathogenesis of human disease. It provides critical analysis and evaluation of which models can genuinely inform the research community about the direct process of human disease, those which may have value in basic toxicology, and those which are simply designed for effective expression and raw characterisation.
期刊最新文献
Balanced actions of estradiol and progesterone—A new paradigm of women’s reproductive health Women’s reproductive system as balanced estradiol and progesterone actions—A revolutionary, paradigm-shifting concept in women’s health Influence of progestagens on bone health. Bone changes related to ovulatory disturbances and low progesterone levels Hereditary bullous diseases: current and innovative models to study the skin blistering disease epidermolysis bullosa The extent and causes of natural variation in menstrual cycles: Integrating empirically-based models of ovarian cycling into research on women’s health
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1